Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain

被引:46
作者
de Mendoza, C
Rodriguez, C
Colomina, J
Tuset, C
Garcia, F
Eiros, JM
Corral, A
Leiva, P
Aguero, JS
Torre-Cisneros, J
Pedreira, J
Viciana, I
del Romero, J
Saez, A
de Lejarazu, RO
Soriano, V [1 ]
机构
[1] Hosp Carlos III, Dept Infect Dis, Madrid 28029, Spain
[2] Ctr Sanitario Sandoval, Madrid, Spain
[3] Gen Hosp, Serv Immunol, Valencia, Spain
[4] Hosp Ribera, Microbiol Serv, Valencia, Spain
[5] Hosp Univ Granada, Microbiol Serv, Granada, Spain
[6] Hosp Clin, Microbiol Serv, Valladolid, Spain
[7] Univ Oviedo, Hosp Cent Asturias, Microbiol Serv, E-33080 Oviedo, Spain
[8] Hosp Marques de Valdecilla, Microbiol Serv, Santander, Spain
[9] Hosp Reina Sofia, Dept Internal Med, Cordoba, Spain
[10] Hosp Juan Canalejo, Dept Internal Med, La Coruna, Spain
[11] Hosp Virgen de la Victoria, Microbiol Serv, Malaga, Spain
关键词
D O I
10.1086/496982
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The prevalence of drug resistance mutations was 12.1% among 198 persons who experienced human immunodeficiency virus (HIV) seroconversion identified in Spain during 1997-2004. There was a significant increase of K103N and of non-B subtypes over time. Transmission of HIV infection around the time of seroconversion was shown in 8 couples and in 2 clusters of 3 individuals.
引用
收藏
页码:1350 / 1354
页数:5
相关论文
共 17 条
[1]  
Balotta C, 2001, J ACQ IMMUN DEF SYND, V27, P499, DOI 10.1097/00126334-200108150-00012
[2]   Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid [J].
Briones, C ;
Pérez-Olmeda, M ;
Rodríguez, C ;
del Romero, J ;
Hertogs, K ;
Soriano, V .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (02) :145-150
[3]   Evidence for differences in the sexual transmission efficiency of HIV strains with distinct drug resistance genotypes [J].
de Mendoza, C ;
Rodriguez, C ;
Corral, A ;
del Romero, J ;
Gallego, O ;
Soriano, V .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (08) :1231-1238
[4]   Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid [J].
de Mendoza, C ;
del Romero, J ;
Rodríguez, C ;
Corral, A ;
Soriano, V .
AIDS, 2002, 16 (13) :1830-1832
[5]   GENETIC-RELATIONSHIPS DETERMINED BY A DNA HETERODUPLEX MOBILITY ASSAY - ANALYSIS OF HIV-1 ENV GENES [J].
DELWART, EL ;
SHPAER, EG ;
LOUWAGIE, J ;
MCCUTCHAN, FE ;
GREZ, M ;
RUBSAMENWAIGMANN, H ;
MULLINS, JI .
SCIENCE, 1993, 262 (5137) :1257-1261
[6]  
Hué S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]
[7]  
*INT AIDS SOC, HIV DRUG MUT
[8]  
Leitner T, 2000, AIDS REV, V2, P241
[9]   Antiretroviral-drug resistance among patients recently infected with HIV [J].
Little, SJ ;
Holte, S ;
Routy, JP ;
Daar, ES ;
Markowitz, M ;
Collier, AC ;
Koup, RA ;
Mellors, JW ;
Connick, E ;
Conway, B ;
Kilby, M ;
Wang, L ;
Whitcomb, JM ;
Hellmann, NS ;
Richman, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :385-394
[10]   Reduced antiretroviral drug susceptibility among patients with primary HIV infection [J].
Little, SJ ;
Daar, ES ;
D'Aquila, RT ;
Keiser, PH ;
Connick, E ;
Whitcomb, JM ;
Hellmann, NS ;
Petropoulos, CJ ;
Sutton, L ;
Pitt, JA ;
Rosenberg, ES ;
Koup, RA ;
Walker, BD ;
Richman, DD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (12) :1142-1149